Scarica l'app Stockscreener
9.21
0.33%
0.03
Dopo l'orario di chiusura:
9.21
Precedente Chiudi:
$9.18
Aprire:
$9.18
Volume 24 ore:
413.30K
Relative Volume:
0.59
Capitalizzazione di mercato:
$1.19B
Reddito:
$1.12B
Utile/perdita netta:
$5.00M
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
$-383.00M
1 W Prestazione:
+0.55%
1M Prestazione:
-11.61%
6M Prestazione:
-48.69%
1 anno Prestazione:
-54.16%
Intervallo 1D:
$9.15
$9.26
Intervallo di 1 settimana:
$8.83
$9.395
Portata 52W:
$7.33
$23.22
Indivior Plc Stock (INDV) Company Profile
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-13 | Iniziato | Northland Capital | Outperform |
Indivior Plc Borsa (INDV) Ultime notizie
242,500 Shares in Indivior PLC (NASDAQ:INDV) Bought by AlphaCentric Advisors LLC - MarketBeat
Indivior completes refinancing of secured term loan - Marketscreener.com
Indivior Extends Its Debt Maturity With Refinancing of Term Loan - BNN Bloomberg
Indivior Boosts Shareholder Value with Repurchase Program - TipRanks
Indivior Boosts Liquidity with $400 Million Refinancing - TipRanks
Indivior PLC Completes Refinance of Secured Term Loan - Marketscreener.com
VELA Investment Management LLC Acquires 108,435 Shares of Indivior PLC (NASDAQ:INDV) - MarketBeat
When the Price of (INDV) Talks, People Listen - Stock Traders Daily
Indivior Announces Total Voting Rights Update - TipRanks
Indivior (LON:INDV) Stock Price Crosses Below 200 Day Moving AverageWhat's Next? - MarketBeat
Suboxone Tooth Decay Lawsuit - Lawsuit Information Center Blog
Sublocade shows promise in opioid disorder recovery By Investing.com - Investing.com Australia
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month - The Malaysian Reserve
Sublocade shows promise in opioid disorder recovery - Investing.com India
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Ab - StreetInsider.com
Indivior PLC Strengthens Position with Share Buyback - TipRanks
Mediolanum International Funds Ltd Purchases Shares of 124,624 Indivior PLC (NASDAQ:INDV) - MarketBeat
Indivior's (INDV) Overweight Rating Reiterated at Piper Sandler - MarketBeat
Indivior price target raised to $16 from $15 at Piper Sandler - TipRanks
Indivior stock target increased, overweight on strong earnings By Investing.com - Investing.com UK
Indivior PLC (INDV) Surpasses Q3 Earnings and Revenue Estimates - MSN
Earnings call: Indivior PLC reports strong Q3 revenue growth, eyes expansion - Investing.com Nigeria
Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive ... - Yahoo Finance
Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive ... By GuruFocus - Investing.com Canada
Indivior Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Indivior (NASDAQ:INDV) Shares Gap UpWhat's Next? - MarketBeat
Severn Trent, Bloomsbury, Indivior: What brokers said today - Proactive financial news
FTSE 250 movers: Softcat, Indivior and Bloomsbury Publishing surge after results - ShareCast
Indivior (LON:INDV) Trading 11.9% HigherWhat's Next? - MarketBeat
Indivior shares motor 11% after reassuring update; brokers positive - Proactive Investors USA
Indivior shares soar 10% after Q3 results beat estimates and guidance update - Investing.com India
Indivior, Humana and Centene report expected settlement of antitrust litigation - TipRanks
Demand for opioid treatment drug drives growth at Indivior - Yahoo Finance UK
Indivior reports Q3 adjusted EPS 54c, consensus 31c - TipRanks
Indivior confident after strong third quarter - ShareCast
Indivior Announces Q3 2024 Financial Results - The Malaysian Reserve
Indivior moves to shore up confidence in Sublocade - Proactive Investors Australia
Indivior PLC Reports Strong Q3 2024 Performance - TipRanks
Indivior PLC (INDV) Q3 2024 Earnings Report Preview: What to Exp - GuruFocus.com
Indivior PLC Continues Aggressive Share Buyback - TipRanks
Two Seas Capital LP Increases Stake in Indivior PLC - Yahoo Finance
Indivior (NASDAQ:INDV) Stock Price Up 3.9%Time to Buy? - MarketBeat
Indivior falls as headwinds to Sublocade prompt another guidance cut - MSN
Indivior PLC Completes Share Buyback Milestone - TipRanks
Indivior to Release Key 2024 Financial Results - TipRanks
Indivior PLC (NASDAQ:INDV) Sees Large Decrease in Short Interest - MarketBeat
Indivior price target lowered to 1,400 GBp from 2,100 GBp at Stifel - TipRanks
Barclays, Bunzl, Indivior: What brokers said today - Proactive financial news
Indivior price target slashed after second profit warning of the year - Proactive Investors USA
Indivior: This Value Stock Has Over 100% Upside Potential If Market Share Stabilizes In 2025 - Seeking Alpha
Indivior price target lowered to $16 from $20 at Craig-Hallum - Yahoo Finance
Indivior Plc Azioni (INDV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.88%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):